Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe.
Chondrogianni ME, Kyrou I, Androutsakos T, Flessa CM, Menenakos E, Chatha KK, Aranan Y, Papavassiliou AG, Kassi E, Randeva HS.
Chondrogianni ME, et al. Among authors: flessa cm.
Front Endocrinol (Lausanne). 2024 Mar 8;15:1344376. doi: 10.3389/fendo.2024.1344376. eCollection 2024.
Front Endocrinol (Lausanne). 2024.
PMID: 38524631
Free PMC article.
Review.